For the Inventor, By the Inventor

Enter assignee name

Sanofi Biotechnology

USPTO Granted Patents = 40

EPO Patents = 33

Trademarks = 24

Forward Citations = 228

Loading Chart...

Loading Chart...

91 inventors (with patents filed for the assignee):

Allen Radin (16 out of 27 patents)

Jennifer D Hamilton (12 out of 14 patents)

Neil John Graham (11 out of 33 patents)

4. Gianluca Pirozzi (8 out of 10 patents)

5. Corinne Hanotin (7 out of 7 patents)

6. Laurence Bessac (7 out of 7 patents)

7. Umesh Chaudhari (6 out of 6 patents)

8. Namita A Gandhi (6 out of 11 patents)

9. Leda Mannent (5 out of 6 patents)

10. William J Sasiela (5 out of 7 patents)

11. Marius Ardeleanu (5 out of 5 patents)

12. Ariel Teper (4 out of 4 patents)

13. Steven P Weinstein (4 out of 7 patents)

14. Marie Baccara-Dinet (3 out of 3 patents)

15. Robert C Pordy (3 out of 10 patents)

Core Competencies:

IL-4R Antagonist

Anti-PCSK9 Antibody

Rheumatoid Arthritis

Asthma Treatment

Atopic Dermatitis

Nasal Polyps

Cholesterol Reduction

Cancer Pain

Eosinophilic Esophagitis

Inflammatory Conditions

Skin Infection

Uveitis

40 patents: Sort by Forward Citations

1. 12708666 - METHODS FOR TREATING ALLERGY AND ENHANCING ALLERGEN-SPECIFIC IMMUNOTHERAPY BY ADMINISTERING AN IL-4R ANTAGONIST (2026-08-18),

2. 12702709 - METHODS FOR TREATING CHRONIC RHINOSINUSITIS WITH NASAL POLYPS BY ADMINISTERING AN ANTIBODY ANTAGONIST OF IL-4R (2026-08-11),

3. 12502429 - METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST (2025-12-23),

4. 12440562 - Method of treating an eye-related disorder by administering an anti-interleukin-4 receptor alpha (anti-IL-4Rα) antibody (2025-10-14),

5. 12440561 - Method of diagnosis and treatment of rheumatoid arthritis (2025-10-14),

6. 12398212 - Methods for treating or preventing asthma by administering an IL-4R antagonist (2025-08-26),

7. 12297279 - Compositions and methods for treating pain in subjects with rheumatoid arthritis (2025-05-13),

8. 12240898 - Monoclonal anti-IL-1RAcP antibodies (2025-03-04),

9. 12083176 - Human antibodies to PCSK9 for use in methods of treating particular groups of subjects (2024-09-10),

10. 12054552 - Humanized anti-IL-1R3 antibody and methods of use (2024-08-06),

11. 12024564 - Humanized anti-IL-1R3 antibodies (2024-07-02),

12. 11932692 - Methods of treating cancer pain by administering a PD-1 inhibitor (2024-03-19),

13. 11845800 - Methods for treating or preventing asthma by administering an IL-4R antagonist (2023-12-19),

14. 11771743 - Methods for preventing or treating allergy by administering an IL-4R antagonist (2023-10-03),

15. 11639392 - Anti-IL-1R3 antibodies for use in inflammatory conditions (2023-05-02),

Company Overview

Sanofi Biotechnology, based in Paris, specializes in the development and manufacturing of biopharmaceuticals. The organization focuses on innovative therapies that leverage biotechnology to address complex medical needs across various therapeutic areas, including oncology, immunology, and rare diseases. With a commitment to advancing healthcare, Sanofi Biotechnology employs cutting-edge research and technology to enhance patient outcomes and drive scientific progress in the biopharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

40 Patents

#151 in Paris

#570 in France

#17,068 in the World

Sanofi Biotechnology

Forward Citations = 228

91 inventors:

Allen Radin (16 out of 27 patents)

Jennifer D Hamilton (12 out of 14 patents)

Neil John Graham (11 out of 33 patents)

4. Gianluca Pirozzi (8 out of 10 patents)

5. Corinne Hanotin (7 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sanofi Biotechnology. Retrieved from https://idiyas.com/company/sanofi-biotechnology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…